Erik Skullerud
Geen lopende functies
Vermogen: 342 $ op 30-04-2024
Loopbaan van Erik Skullerud
Eerdere bekende functies van Erik Skullerud
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
THOR MEDICAL | Algemeen Directeur | 20-09-2021 | 26-08-2022 |
Amgen AB
Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Verkoop & Marketing | 01-09-2004 | 01-05-2016 |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | 01-01-1997 | 01-05-2000 |
Element Consulting GmbH | Oprichter | 01-01-2017 | - |
Corporate Officer/Principal | 01-01-2017 | - |
Opleiding van Erik Skullerud
Handelshögskolan i Göteborg | Undergraduate Degree |
Concordia University | Undergraduate Degree |
Statistieken
Internationaal
Zweden | 3 |
Noorwegen | 2 |
Zwitserland | 2 |
Operationeel
Undergraduate Degree | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Element Consulting GmbH | |
Amgen AB
Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Health Technology |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
- Beurs
- Insiders
- Erik Skullerud
- Ervaring